Skip to main content
. 2021 Mar 10;114(4):164–170. doi: 10.1177/0141076821991108

Figure 1.

Figure 1.

1000-person tool for lung cancer screening. The tool illustrates estimated outcomes based on in the National Lung Screening Trial (NLST). Since the NLST most nodules identified on low-dose computed tomography are followed up using a surveillance protocol, rather than immediate investigation. To reflect contemporary standards of care, this tool assumes the Lung-RADS protocol is used to interpret low-dose computed tomography results. A 1000-person tool has not yet been created to reflect the findings of the NELSON study. Reproduced with permission from the International Agency for Research on Cancer.

Full page infographic available at: https://www.iarc.fr/infographics/benefits-and-harms-of-lung-cancer-screening/